John P Killen, Steven Chadban. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » AnimalsAntibodies, Monoclonal/therapeutic useAntilymphocyte Serum/therapeutic useBasiliximabCadaverDelayed Graft FunctionGraft RejectionHumansImmunosuppressive Agents/therapeutic useKidney TransplantationRabbitsRecombinant Fusion Proteins/therapeutic useRisk Factors
Substances: See more » Antibodies, MonoclonalAntilymphocyte SerumImmunosuppressive AgentsRecombinant Fusion ProteinsBasiliximab
Year: 2007 PMID: 17287486 DOI: 10.1056/NEJMc063467
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245